Merck & Co., Inc. (NYSE: MRK) Q2 2020 earnings call dated July 31, 2020 https://youtu.be/kKm2dyqbeW0 Corporate Participants: Peter Dannenbaum -- Vice President of Investor
Merck & Company Inc.
-(MRK)
Get the latest Merck & Co. (MRK) stock news, earnings analysis, earnings conference calls, earnings transcripts from AlphaStreet.
Merck (MRK) sales decline 8% in Q2 2020; raises FY20 outlook
Merck (NYSE: MRK) reported an 8% drop in second quarter sales, reflecting the negative impact of COVID-19. However, sales of $10.9 billion
Merck & Co (NYSE: MRK) Q1 2020 Earnings Call Transcript
Merck & Co (MRK) Q1 2020 earnings call dated April 28, 2020 Corporate Participants: Peter Dannenbaum -- Vice President of Investor Relations Kenneth C.
Merck (MRK) Q1 Earnings: Key quarterly numbers that you need to note down
Merck (NYSE: MRK) today reported first quarter financial results for the period ended March 31, 2020. On GAAP basis, first quarter EPS
Merck & Co Inc (NYSE: MRK) Q4 2019 Earnings Call Transcript
Merck & Co Inc (NYSE: MRK) Q4 2019 Earnings Conference Call February 05, 2020 Corporate Participants: Peter Dannenbaum -- Vice President of Investor Relations
Merck & Co. (MRK) Q4 earnings beat estimates, revenue slightly misses
Merck & Co., Inc. (NYSE: MRK) reported stronger than expected earnings for the fourth quarter of 2019. However, the company's sales slightly
Where does Merck (MRK) stand in the cancer-drug race?
Shares of Merck and Co. (NYSE: MRK) this week pared some of their recent gains even as the ex-dividend date approaches. While
Merck’s (MRK) Q3 results beat estimates; sales boosted by oncology and vaccines
Merck (NYSE: MRK) surpassed analysts’ expectations for revenue and earnings in the third quarter of 2019, sending the shares climbing 2.5% in
Merck rises on oncology strength post Q2 earnings
Shares of pharmaceutical giant Merck (NYSE: MRK) rose 3% before the market hours on Tuesday after the company reported second-quarter results that
Pharma stocks: Merck is on a buying spree
Several merger and acquisition deals are being announced in the healthcare sector, the most recent one being the acquisition of Array Biopharma
What’s in store for top pharma stocks this year
The stocks of leading pharmaceutical firms shifted to growth mode this year after winding up 2018 on a low note, in line
KEYTRUDA helps Merck to report Q1 earnings beat, raises 2019 outlook
Shares of the pharma giant Merck (MRK) rose 2% before the market hours after the company surpassed estimates on the headline numbers.
Calendar: Earnings of Alphabet, Pfizer, Merck, Apple, Gilead on queue
Alphabet, Pfizer, Merck, Apple, Gilead Sciences, and more earnings are scheduled for the week between April 29 and May 3. Check out
Axsome Therapeutics stock climbs to 34-month high
After the slump on weak quarterly results, investors turned positive on Axsome Therapeutics (AXSM) stock, which climbed to the 34-month high of
Immune Design stock more than triples as it gets acquired by Merck
Merck (MRK) announced today that it will acquire immunotherapy developer Immune Design (IMDZ) for $5.85 per share in cash for an approximate value
Earnings: Array BioPharma delivers strong Q2 results, investors cheer
Array BioPharma (ARRY) reported 44% jump in second-quarter revenue to $82.5 million, driven by higher product sales and recognition of $40 million
Alexion Pharma stock jumps after Q4 results top expectations
Benefitting from the continued sales growth across all markets, led by cancer drug Soliris, Alexion Pharma (ALXN) Monday reported a double-digit increase
Merck’s stock gains after Q4 results beat estimates
Merck’s (MRK) shares climbed over 3% in morning trade on Friday after the company topped revenue and earnings expectations for the fourth
Earnings preview: Merck to ride the wave of expanding oncology portfolio in Q4
The general market sentiment on Merck & Co. (MRK) is quite bullish ahead of the drug maker’s fourth-quarter earnings report. Analysts predict
Merck strengthens animal health division with $2.4-bln Antelliq buyout
Taking a cue from the growing demand for animal care products, healthcare service providers and pharma companies are enhancing their offerings in
Merck announces management changes
Merck (MRK) announced that Adam Schechter, President of Global Human Health (GHH) division will step down from his present role at the